Aurora Cannabis Inc. ($ACB) Stock Forecast: Up 7.4% Today

What is Aurora Cannabis Inc.?

Aurora Cannabis Inc. (ACB) is a Canadian company specializing in medical cannabis products. The stock experienced significant bullish movement recently.

Why is Aurora Cannabis Inc. going up?

ACB stock is up 7.4% on Feb 10, 2025 16:35

• Aurora Cannabis (ACB) stock saw a remarkable 45% increase following its strong performance in Q3. The report highlighted impressive medical cannabis sales and robust financial results.
• Surpassing analyst expectations by 50% in earnings and 9.50% in revenue, the company's earnings report instilled confidence in investors, propelling the stock price upwards.
• Positive market sentiment within the cannabis industry was reinforced by a recent development involving a delay in U.S. tariffs on Canadian goods, further elevating ACB's success.
• Aurora's strategic focus on efficiency, cost-cutting measures, and heightened gross margins also significantly influenced the market's positive response, hinting at a potential resurgence for the company in the competitive cannabis market.

ACB Price Chart

ACB Technical Analysis

ACB News

Is Beam Therapeutics ( BEAM ) Outperforming Other Medical Stocks This Year?

Here is how Beam Therapeutics Inc. (BEAM) and Aurora Cannabis Inc. (ACB) have performed compared to their sector so far this year.

https://www.zacks.com/stock/news/2412869/is-beam-therapeutics-beam-outperforming-other-medical-stocks-this-year

Why Aurora Cannabis Stock Is Skyrocketing Wednesday: What About Canopy, Tilray, Cronos? - Aurora Cannabis ( NASDAQ:ACB )

Aurora Cannabis ( ACB ) stock jumped 45% on strong earnings, driven by record medical cannabis sales. CGC, TLRY and CRON also gained as the sector rallied on Aurora's performance and trade tariff delay news. The U.S. delayed Canada tariffs by 30 days, adding to bullish sentiment for cannabis ...

https://www.benzinga.com/markets/cannabis/25/02/43498531/why-aurora-cannabis-stock-is-skyrocketing-today-what-about-canopy-tilray-and-cronos

Aurora Cannabis Stock Jumps On 'Record-Breaking' Q3 Earnings - Aurora Cannabis ( NASDAQ:ACB )

Aurora Cannabis reported Q3 FY25 net revenue of CA$88.2M, driven by rise in medical cannabis sales and plant propagation. Adjusted EBITDA surged 316% to CA$23.1M, with adjusted gross margin improving to 65%, reflecting higher efficiency and cost reductions.

https://www.benzinga.com/news/earnings/25/02/43496003/aurora-cannabis-stock-jumps-on-record-breaking-q3-earnings

Aurora Cannabis Inc. ( ACB ) Surpasses Q3 Earnings and Revenue Estimates

Aurora Cannabis (ACB) delivered earnings and revenue surprises of 50% and 9.50%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

https://www.zacks.com/stock/news/2409908/aurora-cannabis-inc-acb-surpasses-q3-earnings-and-revenue-estimates

Trending Today

BlackBerry Limited ($BB) Stock Forecast: Up 5.3% Today

Baidu Inc. ($BIDU) Stock Forecast: Up 5.1% Today

Upstart Holdings Inc. ($UPST) Stock Forecast: Up 32.5% Today

Zillow Group Inc. ($Z) Stock Forecast: Down 10.2% Today

Biogen Inc. ($BIIB) Stock Forecast: Down 5.1% Today

CVS Health Corporation ($CVS) Stock Forecast: Up 16.9% Today

Gilead Sciences Inc. ($GILD) Stock Forecast: Up 7.5% Today

Alibaba Group Holding Limited ($BABA) Stock Forecast: Up 5.1% Today

Polkadot ($DOT) Crypto Forecast: Up 5.1% Today

Super Micro Computer Inc ($SMCI) Stock Forecast: Up 5.0% Today

Aurora Cannabis Inc. Price History

01.09.2024 - ACB Stock was down 5.3%

• ACB stock might have experienced a bearish movement due to profit-taking after a recent bullish trend.
• The news about Vice President Kamala Harris's stance on legalizing marijuana could have positively impacted other cannabis stocks like Tilray (TLRY), diverting attention and investment away from ACB.
• Investors might be concerned about ACB's market position and future growth potential compared to its competitors in the cannabis sector.
• The bearish movement in ACB could also be influenced by broader market trends or sector-specific challenges facing the company.

06.10.2024 - ACB Stock was down 17.4%

• ACB surpassed Q2 earnings and revenue expectations significantly but faced a considerable bearish trend.
• Speculations suggest that investors were anticipating even better results, prompting a sell-off post-earnings.
• Concerns may arise regarding future growth potential or market competition in the cannabis sector.
• The bearish trend could also be influenced by profit-taking or broader market sentiment rather than the company's performance.

17.08.2024 - ACB Stock was up 5.0%

• Aurora Cannabis Inc. (ACB) experienced a strong bullish movement today.
• The bullish trend could be attributed to the company's announcement about transforming cannabis cultivation in high-latitude regions through research in auto-flowering technology.
• The market seems to be reacting positively to Aurora's innovative work and potential future breeding strategies, driving the stock price higher.
• Investors are likely optimistic about the company's ability to stay ahead in the cannabis industry through technological advancements, leading to increased demand for ACB shares.

06.08.2024 - ACB Stock was down 5.5%

• Despite Trump's support for marijuana legalization in Florida, Aurora Cannabis (ACB) experienced a bearish movement.
• The market may have reacted negatively due to broader industry concerns or company-specific issues affecting ACB's performance.
• Investors might be cautious about regulatory uncertainties or competitive pressures impacting ACB's growth prospects in the cannabis sector.
• While Trump's endorsement could potentially benefit the industry, ACB's current bearish trend suggests other factors are influencing its stock price.

24.09.2024 - ACB Stock was down 5.8%

• Despite launching medical cannabis oils, Aurora Cannabis (ACB) experienced a strong bearish movement.
• The market might have reacted negatively due to broader industry challenges or specific concerns about ACB's financial performance.
• Investors may have been expecting more significant growth or profitability from the new product launch, leading to disappointment and a sell-off of ACB shares.
• It's essential for traders to monitor both company-specific developments and overall industry trends to make informed decisions in the volatile cannabis market.

20.08.2024 - ACB Stock was down 5.2%

• The stock of Aurora Cannabis (ACB) experienced a bearish movement today.
• The announcement of CEO Miguel Martin taking on the additional role of executive chairman and outgoing chairman Ron Funk transitioning to lead independent director may have caused uncertainty among investors.
• The company's focus on transforming cannabis cultivation in high-latitude regions through research in auto-flowering technology could be seen as a positive long-term strategy, but the immediate market reaction might have been influenced by concerns over leadership changes and potential impact on operations.
• Investors may be cautious about the dual role of the CEO and the implications it could have on the company's strategic direction and decision-making processes, leading to the bearish movement in ACB stock.

08.10.2024 - ACB Stock was down 5.6%

• Aurora Cannabis (ACB) reported strong quarterly earnings that exceeded market expectations, but its share price still fell by 18% due to broader sector pressures, with the cannabis sector experiencing a downturn.
• The cannabis sector as a whole took a sharp downturn after Donald Trump's presidential election victory, leading to major players like Aurora Cannabis seeing double-digit declines in their stock prices.
• Despite beating Q2 earnings and revenue estimates, Aurora Cannabis (ACB) still faced a bearish market movement, possibly due to overall sector pressures and external factors like political events impacting the industry.

05.01.2025 - ACB Stock was up 44.5%

• Aurora Cannabis (ACB) experienced a strong bullish movement today.
• The surge in ACB stock price can be attributed to the company's impressive Q3 earnings report, with record-breaking net revenue of CA$88.2M.
• The significant increase in adjusted EBITDA by 316% to CA$23.1M and improved gross margin of 65% showcase the company's operational efficiency and cost management strategies.
• The positive market response indicates investor confidence in Aurora Cannabis's financial performance and growth prospects, driving the bullish movement in the stock price.

05.01.2025 - ACB Stock was up 47.6%

• Aurora Cannabis (ACB) stock surged by 45% following the release of its Q3 earnings report, which showcased record medical cannabis sales and significant growth in net revenue.
• The strong financial performance, including a 316% increase in adjusted EBITDA and improved gross margin, contributed to the bullish sentiment surrounding ACB stock.
• Additionally, the delay in U.S. tariffs on Canadian imports further boosted the cannabis sector, leading to positive market movement for Aurora Cannabis and other companies like Canopy Growth (CGC), Tilray (TLRY), and Cronos (CRON).

22.09.2024 - ACB Stock was up 6.1%

• The bullish movement in ACB stock today can be attributed to the successful launch of innovative THC oil products in Australia, catering to a diverse range of patient needs.
• The introduction of tailored cannabinoid formulations by ACB and MedReleaf Australia has likely generated positive investor sentiment, driving the stock price higher.
• The expansion of ACB's product range to include premium medical cannabis oils reflects the company's commitment to meeting the evolving demands of the medical cannabis market, potentially attracting more customers and investors alike.

29.09.2024 - ACB Stock was up 5.1%

• Aurora Cannabis (ACB) exhibited a notable bullish movement today, aligning with the positive trend observed in the cannabis sector.
• The upswing in cannabis stocks could be linked to signs of recovery within the industry, leading investors to regain trust in companies like ACB.
• Favorable sentiment and heightened investor attention in the cannabis market may have played a role in the upward trajectory of Aurora Cannabis' stock price.
• The overall market dynamics indicate that ACB is capitalizing on the positive momentum in the cannabis sector, as seen through the gains in other major players like Canopy Growth (CGC) and OrganiGram Holdings (OGI).

10.01.2025 - ACB Stock was up 7.4%

• Aurora Cannabis (ACB) stock saw a remarkable 45% increase following its strong performance in Q3. The report highlighted impressive medical cannabis sales and robust financial results.
• Surpassing analyst expectations by 50% in earnings and 9.50% in revenue, the company's earnings report instilled confidence in investors, propelling the stock price upwards.
• Positive market sentiment within the cannabis industry was reinforced by a recent development involving a delay in U.S. tariffs on Canadian goods, further elevating ACB's success.
• Aurora's strategic focus on efficiency, cost-cutting measures, and heightened gross margins also significantly influenced the market's positive response, hinting at a potential resurgence for the company in the competitive cannabis market.